5-MeO-DMT
Psychedelic tryptamine compound
| Chemical Compound | |
|---|---|
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| ChemSpider ID | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| Properties | |
| Chemical Formula | |
| Molar Mass | |
| Appearance | |
| Density | |
| Melting Point | |
| Boiling Point | |
| Hazards | |
| GHS Pictograms | [[File:|50px]] |
| GHS Signal Word | |
| GHS Hazard Statements | |
| NFPA 704 | [[File:|50px]] |
| References | |
5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine) is a naturally occurring psychedelic of the tryptamine class. It is found in a variety of plant species and in the venom of the Colorado River toad (Incilius alvarius). It is structurally related to DMT (N,N-dimethyltryptamine) and bufotenin (5-HO-DMT).
Chemistry
5-MeO-DMT is a tryptamine derivative, featuring a methoxy group at the fifth position of the indole ring. Its chemical formula is C13H18N2O, and it has a molecular weight of 218.30 g/mol. The compound is typically a white to off-white crystalline solid.
Pharmacology
5-MeO-DMT acts as a serotonin receptor agonist, primarily at the 5-HT2A receptor. It is known for its rapid onset and short duration of action, typically lasting between 30 to 45 minutes when smoked or vaporized. The effects are often described as intense and can include hallucinations, euphoria, and mystical experiences.
Usage
5-MeO-DMT has been used in shamanic practices and modern psychedelic therapy. It is often vaporized or smoked, but it can also be insufflated or taken orally with a monoamine oxidase inhibitor (MAOI).
Legal Status
The legal status of 5-MeO-DMT varies by country. In the United States, it is classified as a Schedule I controlled substance under the Controlled Substances Act. In other countries, it may be regulated differently or remain unscheduled.
Safety and Risks
The use of 5-MeO-DMT carries potential risks, including psychological distress, tachycardia, and hypertension. It is advised to use the substance in a controlled setting with proper harm reduction practices.
See also
References
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
